RNA vaccines

Japan finds another Moderna vial suspected to contain foreign substance

Japan's Kanagawa prefecture said it has found another vial of Moderna Inc's COVID-19 vaccine suspected of containing a foreign substance and has put the rest of the lot on hold.


In a statement on Aug. 31, prefectural authorities said a pharmacist found several black particles in one vial upon checking for foreign substances before the vaccine's use.

Japan Suspends Use of 1.63 Million Jabs of Moderna Vaccine over Safety Concerns

Japan announced it had suspended the use of some 1.63 million Covid-19 Moderna jabs after the domestic distributor received reports of contaminants inside the doses. Both country's officials and representatives of the pharmaceutical company said that no safety or efficacy issues had been identified but still the suspension was just a precaution, Reuters elaborated.

Bad News for Those Inoculated with Pfizer and Moderna Vaccines

The efficacy of anti-COVID-19 vaccines of Pfizer and Moderna companies has decreased from 91 to 66 percent since the Delta variant of the novel coronavirus that causes this infectious disease has become dominant in the United States. This brcame clear from data published by a Federal health agency, Frrance Press reported.

Pfizer-BioNTech COVID-19 vaccine gains full US regulatory approval

The U.S. drug regulator on Aug. 23 granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine - the first to secure such Food and Drug Administration validation - prompting President Joe Biden to make a fresh pitch to vaccine skeptics to get the shot to fight the relentless pandemic.


Israel, US, France and Germany Launch Booster Campaigns as Covid-19 Surges again

A third dose of Pfizer Covid-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received two shots, according to findings published by the Health Ministry and cited by Reuters. The full details of the study were not released.